home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
DP Tool Club 17
/
CD_ASCQ_17_101194.iso
/
vrac
/
med9408d.zip
/
M9480688.TXT
< prev
next >
Wrap
Text File
|
1994-08-27
|
2KB
|
37 lines
Document 0688
DOCN M9480688
TI [Treatment with clarithromycin of 173 HIV+ patients with disseminated
Mycobacterium avium intracellulare infection]
DT 9410
AU Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF;
Truffot C; Chauvin JP; Service de Pneumologie, Groupe Hospitalier
Pitie-Salpetriere,; Paris.
SO Rev Mal Respir. 1994;11(3):271-6. Unique Identifier : AIDSLINE
MED/94316918
AB No treatment was established for disseminated M. avium intracellulare
(MAC) infection, a common disease of end stage of AIDS. An open study
was conducted to assess in 173 AIDS patients, the activity of
clarithromycin. Initial bacteriologic eradication from blood was
observed in 136/147 evaluable patients (93%). Acquired resistance to
clarithromycin associated with relapse appeared to develop after 2 to 7
months of drug treatment in 31/136 patients with initial success. Early
bacteriological relapse was associated with clinical deterioration. Side
effects of drug treatment were elevated liver enzymes (26%) and impaired
hearing (4%). Side effects conducted to stop treatment in 14 cases (8%)
to modified treatment in 8 cases (5%). Our study gave new argues for
activity of clarithromycin in disseminated MAC infection.
DE Adolescence Adult Anti-Infective Agents, Fluoroquinolone/THERAPEUTIC
USE Antibiotics, Combined Antitubercular Agents/THERAPEUTIC USE
AIDS-Related Opportunistic Infections/BLOOD/*DRUG THERAPY/ MICROBIOLOGY
Child Clarithromycin/*THERAPEUTIC USE Clofazimine/THERAPEUTIC USE
Drug Resistance, Microbial English Abstract Female Hearing
Disorders/CHEMICALLY INDUCED/EPIDEMIOLOGY Human Liver Function Tests
Male Middle Age Minocycline/THERAPEUTIC USE Mycobacterium
avium-intracellulare Infection/BLOOD/*DRUG THERAPY/ MICROBIOLOGY
Recurrence Treatment Outcome CLINICAL TRIAL JOURNAL ARTICLE
MULTICENTER STUDY
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).